Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

McGill University

$150,000.00

Characterizing Glioblastoma-Driven Dysregulation of Cell Signaling Within the Subventricular Zone Niche to Identify Novel Therapeutic Targets

FY 2022-23

Summary
Supervisor: Petrecca, Kevin, McGill University Each year 1600 Canadians receive the devastating diagnosis of glioblastoma, an aggressive form of brain cancer. Despite the best available treatments, most patients pass away within 2 years, thus there is a clear need for more effective treatments. Current treatments are failing because they are not effective against cancer stem cells, which have the ability to divide endlessly and reform the tumour after treatment. Learning more about these cancer stem cells is key to developing better treatments. Current research suggests that cancer stem cells in glioblastoma arise from stem cells in the brain that have been mutated. However the mutation isn't sufficient to cause cancer: cancer stem cells are like seeds that need the right environmental conditions to grow. To understand what conditions are needed for cancer to take root, we compare the cell signaling between normal brain stem cells and the surrounding healthy brain tissue, versus the cell signaling between cancer stem cells and the abnormal surrounding tissue. We hypothesize that in the healthy brain, regulatory signals from the tissue environment keep stem cell division tightly controlled, while in glioblastoma, the regulation is disrupted leading to uncontrolled division of cancer stem cells. This study will advance our understanding of how stem cells are regulated in the healthy human brain and how they become dysregulated in glioblastoma. It can also inform the development of new drugs that target these malfunctioning pathways and counter disease progression. Metaphorically, these drugs would make the soil conditions unfavourable so that the cancer cannot grow. We are confident that this study will bring us one step closer to finding an effective treatment for glioblastoma.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
474470
Name
Luo Michael Y
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Characterizing Glioblastoma-Driven Dysregulation of Cell Signaling Within the Subventricular Zone Niche to Identify Novel Therapeutic Targets
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cell Signaling; Glioblastoma; Microenvironment; Neural Stem Cell; Neurooncology; Patient-Derived Explant Model; Spatial Transcriptomics; Subventricular Zone
Abstract
Supervisor: Petrecca, Kevin, McGill University Each year 1600 Canadians receive the devastating diagnosis of glioblastoma, an aggressive form of brain cancer. Despite the best available treatments, most patients pass away within 2 years, thus there is a clear need for more effective treatments. Current treatments are failing because they are not effective against cancer stem cells, which have the ability to divide endlessly and reform the tumour after treatment. Learning more about these cancer stem cells is key to developing better treatments. Current research suggests that cancer stem cells in glioblastoma arise from stem cells in the brain that have been mutated. However the mutation isn't sufficient to cause cancer: cancer stem cells are like seeds that need the right environmental conditions to grow. To understand what conditions are needed for cancer to take root, we compare the cell signaling between normal brain stem cells and the surrounding healthy brain tissue, versus the cell signaling between cancer stem cells and the abnormal surrounding tissue. We hypothesize that in the healthy brain, regulatory signals from the tissue environment keep stem cell division tightly controlled, while in glioblastoma, the regulation is disrupted leading to uncontrolled division of cancer stem cells. This study will advance our understanding of how stem cells are regulated in the healthy human brain and how they become dysregulated in glioblastoma. It can also inform the development of new drugs that target these malfunctioning pathways and counter disease progression. Metaphorically, these drugs would make the soil conditions unfavourable so that the cancer cannot grow. We are confident that this study will bring us one step closer to finding an effective treatment for glioblastoma.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Luo, Michael Y
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
McGill University - $150,000 Grant (2022-23) | Canada Spends